Loading viewer...
conference
Format: PDF conference
Revance Therapeutics presented its 2024 strategic priorities and commercial update at the JP Morgan Healthcare Conference, focusing on DAXXIFY® expansion into therapeutics including cervical dystonia, RHA® dermal fillers pipeline growth, and path to positive adjusted EBITDA. The presentation covers commercialization strategy, market opportunities, and financial guidance for 2024.
investor_presentation
106 Pages
conference
13 Pages
Jupiter Mines
Frasers Centrepoint Trust 2020 UBS Global Real Estate Conference
conferenceconference
25 Pages
Frasers Centrepoint Trust
Syrah Resources 2022 Diggers & Dealers Graphite Presentation
conferenceconference
17 Pages
Syrah Resources Limited